A study led by the Institute for Bioengineering of Catalonia (IBEC) and Pohang University of Science and Technology (POSTECH) in South Korea describes the development of urea-powered nanomotors that improve immunotherapy for bladder cancer. The nanomotors activate the immune system more efficiently and exceed the efficacy of currently used treatments, opening up new possibilities in oncology.
Once again, experts in nanomedicine from various fields gathered in Barcelona on the occasion of World Cancer Day. The meeting provided an opportunity to showcase the latest innovations in nanomedicine for combating cancer, covering topics such as early diagnosis, controlled drug release, and radiotherapy employing nanoparticles.
The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more
BLADDEBOTS is a project led by IBEC researcher Samuel Sánchez, focused on developing nanorobots to treat bladder cancer. To transmit BLADDEBOTS research to society, the researcher has collaborated with the … Read more
Nanobots Therapeutics is the spin-off recently created by the Institute of Bioengineering of Catalonia (IBEC) and the Catalan Institution for Research and Advanced Studies (ICREA) that proposes to develop a … Read more